selective external radiation therapy

RADIATION5 trials

Sponsors

Goshen Health System, Mayo Clinic, Institute of Cancer Research, United Kingdom, Royal Marsden NHS Foundation Trust, SWOG Cancer Research Network

Conditions

Anal CancerBladder CancerCervical CancerColorectal CancerFallopian Tube CancerGastrointestinal ComplicationsLymphomaMetastatic Cancer

Phase 1

3-Dimensional Conformal Radiation Therapy in Treating Patients With Bladder Cancer Who Have Undergone Transurethral Resection of the Bladder

Institute of Cancer Research, United KingdomBladder Cancer

Start: 2009-05-31Target: 60Updated: 2013-08-26

Phase 2

Internal Radiation Therapy With Y-90 Microspheres, External Radiation Therapy With Tomotherapy, and Fluorouracil in Treating Patients With Newly Diagnosed or Recurrent Pancreatic Cancer and Liver Metastases That Cannot Be Removed By Surgery

Goshen Health SystemMetastatic Cancer, Pancreatic Cancer

Start: 2006-11-30Target: 20Updated: 2013-12-19

Combination Chemotherapy, Radiation Therapy, and Sargramostim Before and After Surgery in Treating Patients With Soft Tissue Sarcoma That Can Be Removed By Surgery

CompletedNCT00652860

Mayo ClinicMetastatic Cancer, Sarcoma

Start: 2001-08-31Target: 39Updated: 2011-05-16

S1001 PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma

CompletedNCT01359592

SWOG Cancer Research NetworkLymphoma

Start: 2011-09-30End: 2023-12-31Updated: 2025-06-17

Unknown Phase

Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal Cancer

CompletedNCT01170299

Royal Marsden NHS Foundation TrustAnal Cancer, Bladder Cancer, Cervical Cancer +6

Start: 2009-10-31End: 2014-01-31Target: 177Updated: 2016-11-01

Related Papers

Bladder Tumor-Focused Adaptive Radiation Therapy: Clinical Outcomes of a Phase I Dose Escalation Study

International Journal of Radiation Oncology*Biology*Physics2024-07-273 citations

Development of a Conditional Event-Free Survival Tool in Diffuse Large B-Cell Lymphoma

Blood2022-11-15

Protocol for tumour-focused dose-escalated adaptive radiotherapy for the radical treatment of bladder cancer in a multicentre phase II randomised controlled trial (RAIDER): radiotherapy planning and delivery guidance

BMJ Open2020-12-0134 citations

Prospective phase 1 study assessing feasibility of IMRT and IGART to deliver simultaneous integrated high-dose tumor boost (up to 70 Gy) for the radical treatment of localized muscle-invasive bladder cancer.

Journal of Clinical Oncology2015-03-01